Aberrant lipid metabolism is linked to endometrial cancer, prompting the study of statins as potential therapies, using Mendelian randomization (MR) to explore lipid traits' impact on the cancer.
The study employed two-sample MR, finding no causal relationship between genetically predicted lipid traits and endometrial carcinoma, but identifying drug targets like apolipoprotein B (APOB) and cholesteryl ester transfer protein (CETP) as relevant.
Conclusions indicated no direct link between lipid traits (LDL-C, TG, TC, HDL-C) and endometrial cancer, yet highlighted APOB's association with lower risk and CETP's with higher risk for endometrioid carcinoma, pointing to